CME Group Inc. CME
264.48
(4.43)
(1.65%)
as of 25 Sep
- Market cap
- $96.5B
- P/E
- 22.3×
Follow CME
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
CME Group Inc. (CME) P/S ratio
As of 25 September 2026, CME Group Inc. (CME) trades at a P/S ratio of 14.1×. Over the past ten years it has ranged from 8.3× (January 2016) to 19.2× (March 2022); the current reading is higher than 54% of that period. That is above the Financial Data & Stock Exchanges industry median of 7.8× and above the Financial sector median of 2.3×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 15.1× | 10.63% |
| FY2024 | 13.6× | 1.12% |
| FY2023 | 13.5× | 11.52% |
| FY2022 | 12.1× | (30.83%) |
| FY2021 | 17.5× | 30.89% |
| FY2020 | 13.3× | (9.44%) |
| FY2019 | 14.7× | (1.46%) |
| FY2018 | 14.9× | 11.07% |
| FY2017 | 13.5× | 25.29% |
| FY2016 | 10.7× | 17.28% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 11.8× | (25.10%) |
| Mar 2026 | 15.7× | 4.25% |
| Dec 2025 | 15.1× | (0.85%) |
| Sep 2025 | 15.2× | (1.24%) |
| 42 more quarters | Free account |
Against its own ten years
Low 8.3×
High 19.2×
Ten-year median
13.8×
Current reading's percentile
54
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| TRU TransUnion compare | 2.7× |
| CBOE Cboe Global Markets, Inc. compare | 5.3× |
| NDAQ Nasdaq, Inc. compare | 6.0× |
| SPGI S&P Global Inc. compare | 7.4× |
| COIN Coinbase Global, Inc. compare | 8.2× |
| ICE Intercontinental Exchange Inc. compare | 8.2× |
| MCO Moody's Corporation compare | 10.0× |
| MSCI MSCI Inc compare | 12.1× |
| CME CME Group Inc. | 14.1× |
| Financial Data & Stock Exchanges industry median | 7.8× |
| Financial sector median | 2.3× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CME
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement